BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome

  April 8, 2025

   · 

  8 min read
• Press Releases

  Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: “Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D”

  April 8, 2025

   · 

  2 min read
• Press Releases

  Cerevance Presents Positive Results from Phase 1 Study of CVN293 at American Academy of Neurology 2025 Annual Meeting

  April 8, 2025

   · 

  5 min read
• Press Releases

  QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast

  April 8, 2025

   · 

  1 min read
• Press Releases

  Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

  April 8, 2025

   · 

  13 min read
• Press Releases

  Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

  April 8, 2025

   · 

  7 min read
• Press Releases

  Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025

  April 8, 2025

   · 

  1 min read
• Press Releases

  U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1

  April 8, 2025

   · 

  19 min read
• Press Releases

  AbCellera to Participate at Upcoming Investor Conferences in May and June

  April 8, 2025

   · 

  1 min read
• Press Releases

  Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update

  April 8, 2025

   · 

  15 min read